Document is current
Any future updates will be listed below
-
Authors
Ludwig, Mareike
Pereira, Calida
Keute, Marius
Düzel, Emrah
Betts, Matthew J.
Hämmerer, Dorothea
- License Information
-
More Information
Article History
Received: 10 November 2023
Accepted: 4 September 2024
First Online: 17 October 2024
Competing interests
: E.D has received payments for his role and works as consultant for Roche, Biogen, RoxHealth and expert testimony for UCL Consultancy, served at scientific advisory boards for EdoN Initiative and Ebsen Alzheimers Center (no payment) and Roche (personal financial support), and is a co-founder of the digital health start-up Neotiv. M.L., C.P., M.K., M.J.B., D.H. have nothing to disclose.
: The study was approved by the Ethics Committee of medical faculty at the Otto von Guericke University of Magdeburg (reference no. 107/20) and was carried out in accordance with the ethical standards of Helsinki. A written informed consent was obtained from each subject before participation, and they were reimbursed with 90 Euros.
